Bora Biologics, a contract drug manufacturing organization specializing in microbial- and mammalian-expressed therapeutics, celebrated the opening of its expanded FDA-approved manufacturing facility in San Diego with a ribbon-cutting ceremony attended by company leadership, employees, community partners, and San Diego Mayor Todd Gloria.

The $30 million facility expansion adds state-of-the-art upstream and downstream GMP processing capabilities to meet the growing demand for 2,000-liter scale single-use biologics manufacturing. The expansion features two to four 2,000-liter bioreactors, corresponding seed trains, and advanced downstream processing equipment, significantly increasing Bora Biologics’ U.S.-based biologics manufacturing capacity for the local and global biotech community.

“This expansion marks an important milestone for Bora Biologics and reflects our commitment to supporting the development and manufacture of high-quality, life-saving biologics,” said Stephen Lam, CEO of Bora Biologics. “By opening this expanded GMP facility in San Diego, we are enhancing our ability to serve our partners while contributing to job creation and continued growth in the region’s life sciences sector. The investment strengthens our ability to support programs in the U.S. as they advance from late-stage development into commercial supply.” John R. Mosack, General Manager & Vice President of Operations for Bora Biologics’ San Diego site added, “With this expansion, we can now offer our customers 2000-liter commercial manufacturing capacity with the infrastructure and expertise to purify modern, high-titer cell culture processes.”

Mayor Todd Gloria highlighted the importance of ongoing investment in San Diego’s biotechnology ecosystem. “Bora Biologics’ expansion reinforces San Diego’s position as a global leader in life sciences and advanced manufacturing,” said San Diego Mayor Todd Gloria. “This investment means good-paying jobs, long-term economic growth, and the ability to manufacture life-saving medicine right here at home. It shows what’s possible when innovative companies and local government work together to keep cutting-edge science growing in San Diego.”

With the opening of the expanded facility, Bora Biologics further strengthens its end-to-end biologics development and manufacturing capabilities, supporting programs from early development through commercial supply.